Subscribe Now
Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹807.0
₹193,626 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,050.0
₹107,513 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,407.0
₹73,340 Cr
Pharmaceuticals & Drugs
₹904.1
₹72,944 Cr
Hospital & Healthcare Services
₹4,478.5
₹64,394 Cr
Pharmaceuticals & Drugs
₹2,358.3
₹56,283 Cr
Pharmaceuticals & Drugs
₹3,395.0
₹55,780 Cr
Pharmaceuticals & Drugs
₹3,160.6
₹53,479 Cr
Pharmaceuticals & Drugs
₹3,454.3
₹41,301 Cr
Pharmaceuticals & Drugs
₹395.7
₹40,510 Cr

Top Healthcare Sector Companies in India by Revenues - Consolidated

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹807.0
₹36,704 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹904.1
₹21,110 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,407.0
₹20,442 Cr
Pharmaceuticals & Drugs
₹395.7
₹15,453 Cr
Hospital & Healthcare Services
₹4,478.5
₹13,105 Cr
Pharmaceuticals & Drugs
₹2,358.3
₹12,584 Cr
Pharmaceuticals & Drugs
₹3,454.3
₹10,042 Cr
Pharmaceuticals & Drugs
₹3,160.6
₹8,316 Cr
Pharmaceuticals & Drugs
₹4,050.0
₹7,438 Cr
Pharmaceuticals & Drugs
₹3,395.0
₹4,185 Cr

Top Healthcare Sector Companies in India by Net Profit - Consolidated

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹807.0
₹6,263 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹904.1
₹2,598 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹395.7
₹2,361 Cr
Pharmaceuticals & Drugs
₹4,050.0
₹2,136 Cr
Pharmaceuticals & Drugs
₹4,407.0
₹1,887 Cr
Pharmaceuticals & Drugs
₹3,454.3
₹1,752 Cr
Pharmaceuticals & Drugs
₹3,160.6
₹1,219 Cr
Pharmaceuticals & Drugs
₹3,395.0
₹1,186 Cr
Hospital & Healthcare Services
₹4,478.5
₹1,041 Cr
Pharmaceuticals & Drugs
₹2,358.3
₹714 Cr

STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

You may also like the below Video Courses

All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z